Maria La Mantia

<i>BRCA1/2</i> pathogenic variants in triple-negative <i>versus</i> luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients

Lorena Incorvaia, Daniele Fanale, Marco Bono et al. · Therapeutic Advances in Medical Oncology · 2020 · 64 citations · Full text

Medicine, Genetics, Oncology +17

Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—a trial-level meta-analysis in PD-L1 selected subgroups

Francesco Passiglia, Antonio Galvano, Valerio Gristina et al. · Translational Lung Cancer Research · 2021 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

Technical and clinical validation of a new immunoradiometric assay for human osteocalcin

J.C. Dumon, H Wantier, F. Mathieu et al. · European Journal of Endocrinology · 1996 · 28 citations

Medicine, Endocrinology, Bone Metabolism +13

Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study

Valerio Gristina, Nadia Barraco, Maria La Mantia et al. · Cancers · 2022 · 24 citations · Full text

Medicine, Molecular Medicine, Oncology +17

The diagnostic accuracy of <i>PIK3CA</i> mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis

Antonio Galvano, Luisa Castellana, Valerio Gristina et al. · Therapeutic Advances in Medical Oncology · 2022 · 21 citations · Full text

Medicine, Molecular Genetics, Oncology +17